Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will convene its board of directors on 27 April 2026 to consider and approve the group’s unaudited financial results for the three months ended 31 March 2026. The agenda also allows for the handling of other potential business items.

The current board comprises five executive directors—Li Xiaojun, Chen Jiehui, Cheng Hongjin, Tang Heping and Li Hong—and four independent non-executive directors—Chen Yajin, Huang Min, Wong Lung Tak Patrick and Sun Baoqing.

The announcement was released from Guangzhou on 14 April 2026.